Clinical Trials Logo

Left Atrial Appendage clinical trials

View clinical trials related to Left Atrial Appendage.

Filter by:
  • None
  • Page 1

NCT ID: NCT05951101 Recruiting - Stroke Clinical Trials

Zenith LAA Occlusion System

Start date: February 28, 2024
Phase: N/A
Study type: Interventional

Demonstrate the safety and performance of the Zenith LAA Occlusion System and procedure to occlude the Left Atrial Appendage (LAA) from the left atrium (LA) using a minimally invasive technique. Indication - LAA closure in patients with non-valvular atrial fibrillation, with an ostial diameter between 18 mm and 26 mm

NCT ID: NCT04897204 Not yet recruiting - Atrial Fibrillation Clinical Trials

Left Atrial Appendage Electrical Isolation in Persistent Atrial Fibrillation

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

This project intends to enroll patients with persistent atrial fibrillation who are planning to undergo catheter ablation of atrial fibrillation. The two groups of patients were routinely performed atrial fibrillation pulmonary vein isolation and linear ablation with left atrial appendage occlusion. The experimental group received additional left atrial appendage electrical isolation before the left atrial appendage occlusion, and the control group did not perform left atrial appendage electrical isolation. We are intend to evaluate the safety and effectiveness of one-stop operation of left atrial appendage electrical isolation combined with left atrial appendage occlusion in the treatment of persistent atrial fibrillation.

NCT ID: NCT03133806 Recruiting - Clinical trials for Non-Valvular Atrial Fibrillation

Canadian Left Atrial Appendage Closure Study

CLASS
Start date: February 15, 2017
Phase: N/A
Study type: Interventional

The purpose of the study is to demonstrate the safety and the rate of closure of the Ultrasept Left Atrial Appendage (LAA) Closure System for the percutaneous occlusion of the left atrial appendage in patients with non-valvular atrial fibrillation.

NCT ID: NCT01962051 Withdrawn - Stroke Clinical Trials

AMPLATZER Cardiac Plug (ACP) Latin American Post Market Observational

ACP LA
Start date: October 2013
Phase:
Study type: Observational

The ACP device will be clinically evaluated through a prospective, open-label, nonrandomized, multi-center post market clinical study.

NCT ID: NCT01786486 Completed - Stroke Clinical Trials

AMPLATZER Cardiac Plug (ACP) Registry-Long Term Follow-up Protocol

ACPR
Start date: August 2009
Phase:
Study type: Observational [Patient Registry]

The objective of the AMPLATZER Cardiac Plug (ACP) Registry Long Term Follow-up study is to evaluate long term performance of the ACP in closure of the Left Atrial Appendage (LAA) in subjects with nonvalvular atrial fibrillation and assess adverse events up to two (2) or more years post implant.

NCT ID: NCT01522911 Active, not recruiting - Atrial Fibrillation Clinical Trials

Atrial and Brain Natriuretic Peptide Secretion After Percutaneous Closure of the Left Atrial Appendage

Start date: May 2010
Phase: N/A
Study type: Interventional

To date there are no data suggesting substantial effects of hormonal interaction after percutaneous closure of the left atrial appendage (LAA). Our hypothesis is that by excluding the LAA from blood flow physiologic stimuli for ANP and BNP produce may be impaired and consecutive release of the hormones may be reduced. Here, we present our experience of ANP and BNP secretion in the early postprocedural period after transcatheter closure of the LAA.